Innovative techniques for tissue engineering have a tremendous impact on the future of the medical world. 3D bio-printing is a transformational technology which holds great promise for the development of processes in the fields of tissue engineering and regenerative medicine, and consequently, the future of medicine. Omid Afarinan Mohandesi Ayande Company, shortly called 3D-Bio team, started its work in 2016, believing that it could build the future by combining the specialists’ spirit of cooperation and cutting-edge solutions. Within a short period of time, the group has been able to gain a special place by offering various types of bio-printer devices with unique features, as well as providing special services in the field of tissue engineering and 3D bioprinting.
3D bioprinting is an emerging technology used to design and rebuild 3D cellular constructs with the aim of replacing missing organs, drug screening and also cosmetics. The most striking advantage of this technology is its ability to create 3D structures with living biological components such as cells and their extracellular matrix.
In 3D bioprinting, the precise layer by layer placement of biological materials, biochemical cues and living cells with a similar structure to native tissues are used to create a three-dimensional construct. Researchers around the world are attempting to produce a 3D biological structure with appropriate biological and mechanical properties for lost tissues and organs substitution. One of the most important challenges is that this technology was previously used to print polymers and metals and now should be used to print biological, viable and sensitive materials. However, the ultimate goal of the research teams is to produce constructs that are very similar to the extracellular matrix in macrostructure and contain a suitable number and different types of cells.